• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半胱氨酸蛋白酶及其抑制剂在恶性黑色素瘤和其他肿瘤细胞运动中的可能作用。

A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumour cells.

作者信息

Boike G, Lah T, Sloane B F, Rozhin J, Honn K, Guirguis R, Stracke M L, Liotta L A, Schiffmann E

机构信息

Department of Pharmacology, Wayne State University, Detroit, MI.

出版信息

Melanoma Res. 1992 Jan-Feb;1(5-6):333-40. doi: 10.1097/00008390-199201000-00004.

DOI:10.1097/00008390-199201000-00004
PMID:1422189
Abstract

The metastasis of malignant tumour cells depends on their rapid replication, and their ability to adhere to the matrix of a biological barrier such as basement membrane, to degrade the matrix, and to migrate through this more permeable barrier. Secreted enzymes, including the cysteine proteinases cathepsins B and L, are known to degrade basement membrane components. Using a barrier-free substratum we studied the possible role of cysteine proteinases in influencing the motility per se of metastatic cells. We found that stefins, the natural inhibitors of cysteine proteinases, markedly decreased the stimulated motility of both human melanoma cells and W256 carcinosarcoma cells at low concentrations (0.5 microM). A stefin also inhibited melanoma cell adherence, but to a lesser extent than motility. Additionally, synthetic inhibitors (E-64, diazomethyl ketones) of cysteine proteinases were found to depress stimulated motility of W256 cells. These results suggest that cysteine proteinases and their inhibitors may have a direct role in the development of a migratory response per se in tumour cells.

摘要

恶性肿瘤细胞的转移取决于其快速复制的能力,以及它们黏附于生物屏障(如基底膜)基质、降解该基质并穿过这一通透性更高的屏障进行迁移的能力。已知包括半胱氨酸蛋白酶组织蛋白酶B和L在内的分泌酶可降解基底膜成分。我们使用无屏障基质研究了半胱氨酸蛋白酶在影响转移细胞自身运动性方面可能发挥的作用。我们发现,半胱氨酸蛋白酶的天然抑制剂丝抑蛋白在低浓度(0.5微摩尔)时可显著降低人黑色素瘤细胞和W256癌肉瘤细胞的刺激运动性。一种丝抑蛋白还可抑制黑色素瘤细胞的黏附,但抑制程度低于对运动性的抑制。此外,还发现半胱氨酸蛋白酶的合成抑制剂(E-64、重氮甲基酮)可抑制W256细胞的刺激运动性。这些结果表明,半胱氨酸蛋白酶及其抑制剂可能在肿瘤细胞迁移反应的发生过程中直接发挥作用。

相似文献

1
A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumour cells.半胱氨酸蛋白酶及其抑制剂在恶性黑色素瘤和其他肿瘤细胞运动中的可能作用。
Melanoma Res. 1992 Jan-Feb;1(5-6):333-40. doi: 10.1097/00008390-199201000-00004.
2
Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.黑色素瘤患者血清中的组织蛋白酶B、H和L及其抑制剂丝抑素A和胱抑素C。
Clin Cancer Res. 1997 Oct;3(10):1815-22.
3
Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines.细胞密度增加会降低两种前列腺肿瘤细胞系的半胱氨酸蛋白酶抑制剂活性,并增强其侵袭能力。
Cancer Lett. 2002 Nov 28;185(2):163-72. doi: 10.1016/s0304-3835(02)00275-6.
4
Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.组织蛋白酶L+B活性降低以及PC3前列腺癌细胞侵袭能力降低。
Biotech Histochem. 2003 Apr;78(2):101-8. doi: 10.1080/10520290310001593856.
5
Effect of cysteine proteinase inhibitors on murine B16 melanoma cell invasion in vitro.半胱氨酸蛋白酶抑制剂对小鼠B16黑色素瘤细胞体外侵袭的影响。
Biol Chem. 2002 May;383(5):839-42. doi: 10.1515/BC.2002.088.
6
The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation.胱抑素C、组织蛋白酶B和组织蛋白酶L在小鼠胚胎着床和胎盘形成过程中的表达及功能
Development. 1997 Sep;124(17):3415-25. doi: 10.1242/dev.124.17.3415.
7
Human cysteine proteinases and their protein inhibitors stefins, cystatins and kininogens.人类半胱氨酸蛋白酶及其蛋白质抑制剂,即丝氨酸蛋白酶抑制剂、胱抑素和激肽原。
Biomed Biochim Acta. 1986;45(11-12):1375-84.
8
Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity.基质金属蛋白酶而非组织蛋白酶B、H和L或类风湿关节炎患者外周血中的它们的抑制剂,可能是疾病活动的有用标志物。
Z Rheumatol. 1998 Dec;57(6):392-8. doi: 10.1007/s003930050131.
9
Inhibition of bovine cathepsins L and S by stefins and cystatins.丝氨酸蛋白酶抑制剂和半胱氨酸蛋白酶抑制剂对牛组织蛋白酶L和S的抑制作用。
Biol Chem Hoppe Seyler. 1996 May;377(5):319-21.
10
Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients.组织蛋白酶B、组织蛋白酶L、丝抑素A和丝抑素B与尿激酶及纤溶酶原激活物抑制剂-1作为潜在生物标志物的比较及乳腺癌患者的临床病理数据
Cancer Detect Prev. 2002;26(1):42-9. doi: 10.1016/s0361-090x(02)00015-6.

引用本文的文献

1
Identification of Keratinocyte Differentiation-Involved Genes for Metastatic Melanoma by Gene Expression Profiles.基于基因表达谱鉴定角质形成细胞分化相关基因在转移性黑色素瘤中的作用。
Comput Math Methods Med. 2021 Dec 28;2021:9652768. doi: 10.1155/2021/9652768. eCollection 2021.
2
Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target.皮肤恶性黑素瘤中的蛋白酶:作为生物标志物和治疗靶点的相关性。
Cell Mol Life Sci. 2010 Dec;67(23):3947-60. doi: 10.1007/s00018-010-0469-5. Epub 2010 Aug 5.
3
Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.
肿瘤细胞的迁移和转移:以自分泌运动因子为例的细胞外酶细胞因子。
Pathol Oncol Res. 1997 Sep;3(3):230-54. doi: 10.1007/BF02899927.
4
Cathepsin L increases invasion and migration of B16 melanoma.组织蛋白酶L增加B16黑色素瘤的侵袭和迁移能力。
Cancer Cell Int. 2007 May 8;7:8. doi: 10.1186/1475-2867-7-8.
5
Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.蛋白酶解-抗蛋白酶解平衡及其在致癌作用中的调节
World J Gastroenterol. 2005 Mar 7;11(9):1251-66. doi: 10.3748/wjg.v11.i9.1251.
6
Proteinase inhibitors reduce basement membrane degradation by human breast cancer cell lines.蛋白酶抑制剂可减少人乳腺癌细胞系对基底膜的降解。
Br J Cancer. 1997;75(7):951-9. doi: 10.1038/bjc.1997.166.
7
Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64.半胱氨酸蛋白酶抑制剂E-64对癌细胞侵袭和肝转移形成的抑制作用
Clin Exp Metastasis. 1997 Mar;15(2):121-9. doi: 10.1023/a:1018496625936.